Education
About Us
Working with TipRanks
Follow Us
SOPHiA GENETICS (SOPH)
NASDAQ:SOPH
Total Valuation
SOPHiA GENETICS has a market cap or net worth of $200.49M. The enterprise value is -$12.52M.
Market Cap$200.49M
Enterprise Value-$12.52M
Share Statistics
SOPHiA GENETICS has 66,831,070 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding66,831,070
Owned by Insiders―
Owned by Institutions19.84%
Financial Efficiency
SOPHiA GENETICS’s return on equity (ROE) is -0.65 and return on invested capital (ROIC) is -51.95%.
Return on Equity (ROE)-0.65
Return on Assets (ROA)-0.40
Return on Invested Capital (ROIC)-51.95%
Return on Capital Employed (ROCE)-0.52
Revenue Per Employee154.07K
Profits Per Employee-144.85K
Employee Count423
Asset Turnover0.42
Inventory Turnover3.62
Valuation Ratios
The current PE Ratio of SOPHiA GENETICS is -3.25. SOPHiA GENETICS’s PEG ratio is 0.00.
PE Ratio-3.25
PS Ratio0.00
PB Ratio48.09
Price to Fair Value2.10
Price to FCF-30.83
Price to Operating Cash Flow-33.78
PEG Ratio0.00
Income Statement
In the last 12 months, SOPHiA GENETICS had revenue of 65.17M and earned -62.49M in profits. Earnings per share was -0.95.
Revenue65.17M
Gross Profit43.94M
Operating Income-66.57M
Pretax Income-61.27M
Net Income-62.49M
EBITDA-51.49M
Earnings Per Share (EPS)-0.95
Cash Flow
In the last 12 months, operating cash flow was -40.24M and capital expenditures -5.40M, giving a free cash flow of -45.65M billion.
Operating Cash Flow-40.24M
Free Cash Flow-45.65M
Free Cash Flow per Share-0.68
Dividends & Yields
SOPHiA GENETICS pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.33
52-Week Price Change-39.96%
50-Day Moving Average2.96
200-Day Moving Average3.38
Relative Strength Index (RSI)46.32
Average Volume (3m)33.39K
Important Dates
SOPHiA GENETICS upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.
Last Earnings DateMay 6, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend Date―
Financial Position
SOPHiA GENETICS as a current ratio of 3.71, with Debt / Equity ratio of 38.04%
Current Ratio3.71
Quick Ratio3.49
Debt to Market Cap0.07
Net Debt to EBITDA0.97
Interest Coverage Ratio-34.80
Taxes
In the past 12 months, SOPHiA GENETICS has paid 1.22M in taxes.
Income Tax1.22M
Effective Tax Rate-0.02
Enterprise Valuation
SOPHiA GENETICS EV to EBITDA ratio is -2.96, with an EV/FCF ratio of -2.99.
EV to Sales2.34
EV to EBITDA-2.96
EV to Free Cash Flow-2.99
EV to Operating Cash Flow-3.56
Balance Sheet
SOPHiA GENETICS has $68.53M in cash and marketable securities with $30.13M in debt, giving a net cash position of -$38.40M billion.
Cash & Marketable Securities$68.53M
Total Debt$30.13M
Net Cash-$38.40M
Net Cash Per Share-$0.57
Tangible Book Value Per Share$1.02
Margins
Gross margin is 70.30%, with operating margin of -102.14%, and net profit margin of -95.89%.
Gross Margin70.30%
Operating Margin-102.14%
Pretax Margin-94.01%
Net Profit Margin-95.89%
EBITDA Margin-79.00%
EBIT Margin-91.08%
Analyst Forecast
The average price target for SOPHiA GENETICS is $5.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$5.75
Price Target Upside91.67% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast4.66%
EPS Growth Forecast11.33%